| 3DDS: reference: Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy., Thomson SA, Banker P, Bickett DM, Boucheron JA, Carter HL, Clancy DC, Cooper JP, Dickerson SH, Garrido DM, Nolte RT, Peat AJ, Sheckler LR, Sparks SM, Tavares FX, Wang L, Wang TY, Weiel JE, Bioorg Med Chem Lett. 2008 Dec 25. PMID: 19138846 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).